Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorAkbulut, Yasin
dc.contributor.authorGül, Mehmet
dc.contributor.authorDündar, Serkan
dc.contributor.authorÖzcan, Erhan Cahit
dc.contributor.authorÖzercan, İbrahim Hanifi
dc.contributor.authorBozoğlan, Alihan
dc.contributor.authorKarasu, Necmettin
dc.contributor.authorAcıkan, İzzet
dc.contributor.authorBingül, Muhammet Bahattin
dc.date.accessioned2022-05-24T08:55:19Z
dc.date.available2022-05-24T08:55:19Z
dc.date.issued2021en_US
dc.identifier.citationAkbulut, Y., Gul, M., Dundar, S., Ozcan, E. C., Ozercan, I. H., Bozoglan, A., ... & Bingül, M. B. (2021). Evaluation of Effects of Systemic Zoledronic Acid Application on Bone Maturation in the Consolidation Period in Distraction Osteogenesis. Journal of Craniofacial Surgery, 32(8), 2901-2905.en_US
dc.identifier.issn1536-3732
dc.identifier.urihttps://doi.org/10.1097/SCS.0000000000007698
dc.identifier.urihttps://hdl.handle.net/20.500.12933/1064
dc.description.abstractDistraction osteogenesis (DO) is a physiological process that generates new bone tissue formation, using progressively separated bone fragments. Recently, several techniques have been investigated to develop the maturation of the new bone tissue. Bisphosphonates was an effective material for the acceleration of bone formation in DO procedures. The purpose of this study was to evaluate the effects of the systemic zoledronic acid application at the beginning of the consolidation period on new bone genesis in a DO model of rat femurs. The rats were divided randomly into 3 groups, as follows: Control group (CNT group) (n = 10), zoledronic acid dosage-1 (n = 10), and dosage-2 (n = 10) groups (ZA-D-1 and ZA-D-2). No treatment was administered in controls, but DO was applied to the rat femurs. A single dose of 0.1 mg/kg and 0.2 mg/kg of zoledronic acid was administered systematically at the beginning of the consolidation period after the distraction in treatment groups, respectively. Histomorphometric analyses were performed on the original distracted bone area and the surrounding bone tissue. Osteoblasts, new bone formation, and fibrosis were scored. New bone formation in the ZA-D-1 and ZA-D-2 groups, when compared with the control group, was detected highly (P < 0.05). The numbers of osteoblasts in the ZA-D-1 and ZA-D-2 groups were higher when compared with the controls (P < 0.05). Fibrosis in the controls, when compared with the ZA-D-1 and ZA-D-2 groups, was found to be higher (P < 0.05). Zoledronic acid application is an effective method for bone maturation in consolidation period in DO.en_US
dc.language.isoengen_US
dc.publisherLippincott, Williams & Wilkinsen_US
dc.relation.isversionof10.1097/SCS.0000000000007698en_US
dc.rightsinfo:eu-repo/semantics/embargoedAccessen_US
dc.subjectBisphosphonateen_US
dc.subjectBoneen_US
dc.subjectDistraction osteogenesisen_US
dc.subjectFemuren_US
dc.subjectZoledronic aciden_US
dc.titleEvaluation of Effects of Systemic Zoledronic Acid Application on Bone Maturation in the Consolidation Period in Distraction Osteogenesisen_US
dc.typearticleen_US
dc.authorid0000-0002-2971-3536en_US
dc.departmentAFSÜ, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü, Plastik Rekonstrüktif ve Estetik Cerrahien_US
dc.contributor.institutionauthorÖzercan, İbrahim Hanifi
dc.identifier.volume32en_US
dc.identifier.issue8en_US
dc.identifier.startpage2901en_US
dc.identifier.endpage2905en_US
dc.relation.journalJournal of Craniofacial Surgeryen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster